An in vitro co-culture model of esophageal cells identifies ascorbic acid as a modulator of cell competition

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Merlo, Lauren M F ^a   Kosoff, Rachelle E ^b   Gardiner, Kristin L ^a   Maley, Carlo C ^a,c  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; EPIDERMAL GROWTH FACTOR;

APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CELL COMPETITION; CELL CULTURE; CELL GROWTH; CELL INTERACTION; CELL TYPE; CONTROLLED STUDY; ESOPHAGUS; FLOW CYTOMETRY; FLUORESCENCE; GASTROINTESTINAL REFLUX; HUMAN; HUMAN CELL; PH; SQUAMOUS CELL; TUMOR CELL; CELL LINE; CELL PROLIFERATION; COCULTURE; DRUG EFFECT; EPITHELIUM CELL; METABOLISM;

APOPTOSIS; ASCORBIC ACID; BARRETT ESOPHAGUS; CELL LINE, TRANSFORMED; CELL PROLIFERATION; COCULTURE TECHNIQUES; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; ESOPHAGUS; HUMANS;

EID: 80054865553     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-461     Document Type: Article

References (53)

1. Merlo LMF, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nat Rev Cancer 2006, 6:924-935. 10.1038/nrc2013, 17109012.
2. Maley CC, Reid BJ, Forrest S. Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity. Cancer Epidemiol Biomarkers Prev 2004, 13:1375-1384.
3. Galipeau PC, Prevo LJ, Sanchez CA, Longton GM, Reid BJ. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst 1999, 91:2087-2095. 10.1093/jnci/91.24.2087, 1559996, 10601379.
4. Wong DJ, Paulson TG, Prevo LJ, Galipeau PC, Longton G, Blount PL, Reid BJ. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 2001, 61:8284-8289.
5. Siegmund KD, Marjoram P, Tavaré S, Shibata D. Many colorectal cancers are "flat" clonal expansions. Cell Cycle 2009, 8:2187-2193. 10.4161/cc.8.14.9151, 19556889.
6. Majewski T, Lee S, Jeong J, Yoon DS, Kram A, Kim MS, Tuziak T, Bondaruk J, Lee S, Park WS, Tang KS, Chung W, Shen L, Ahmed SS, Johnston DA, Grossman HB, Dinney CP, Zhou JH, Harris RA, Snyder C, Filipek S, Narod SA, Watson P, Lynch HT, Gazdar A, Bar-Eli M, Wu XF, McConkey DJ, Baggerly K, Issa JP, Benedict WF, Scherer SE, Czerniak B. Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy. Lab Invest 2008, 88:694-721. 10.1038/labinvest.2008.27, 2849658, 18458673.
7. Miller BE, Miller FR, Heppner GH. Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors. Cancer Res 1989, 49:3747-3753.
8. Miller BE, Machemer T, Lehotan M, Heppner GH. Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors. Cancer Res 1991, 51:4378-4387.
9. Heng HHQ, Bremer SW, Stevens JB, Ye KJ, Liu G, Ye CJ. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective. J Cell Physiol 2009, 220:538-547. 10.1002/jcp.21799, 19441078.
10. Caignard A, Martin MS, Michel MF, Martin F. Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. Int J Cancer 1985, 36:273-279. 10.1002/ijc.2910360221, 4018914.
11. Guba M, Cernaianu G, Koehl G, Geissler EK, Jauch KW, Anthuber M, Falk W, Steinbauer M. A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res 2001, 61:5575-5579.
12. Miller BE, Miller FR, Leith J, Heppner GH. Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor. Cancer Res 1980, 40:3977-3981.
13. Baker NE, Li W. Cell competition and its possible relation to cancer. Cancer Res 2008, 68:5505-5507. 10.1158/0008-5472.CAN-07-6348, 18632598.
14. Heppner G, Miller B, Cooper DN, Miller FR. Growth interactions between mammary tumor cells. Cell Biology of Breast Cancer 1980, 161-172. New York: Acadmic Press, McGrath C, Brennan M, Rich M.
15. Tamori Y, Bialucha CU, Tian AG, Kajita M, Huang YC, Norman M, Harrison N, Poulton J, Ivanovitch K, Disch L, Liu T, Deng WM, Fujita Y. Involvement of Lgl and Mahjong/VprBP in cell competition. PLoS Biol 2010, 8:e1000422. 10.1371/journal.pbio.1000422, 2903597, 20644714.
16. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA. Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci USA 2010, 107:18545-18550. 10.1073/pnas.1010978107, 2972991, 20876136.
17. Hogan C, Kajita M, Lawrenson K, Fujita Y. Interactions between normal and transformed epithelial cells: Their contributions to tumourigenesis. Int J Biochem Cell Biol 2011, 43:496-503. 10.1016/j.biocel.2010.12.019, 21187160.
18. Hogan C, Dupré-Crochet S, Norman M, Kajita M, Zimmermann C, Pelling AE, Piddini E, Baena-López LA, Vincent JP, Itoh Y, Hosoya H, Pichaud F, Fujita Y. Characterization of the interface between normal and transformed epithelial cells. Nat Cell Biol 2009, 11:460-467. 10.1038/ncb1853, 19287376.
19. Kajita M, Hogan C, Harris AR, Dupre-Crochet S, Itasaki N, Kawakami K, Charras G, Tada M, Fujita Y. Interaction with surrounding normal epithelial cells influences signalling pathways and behaviour of Src-transformed cells. J Cell Sci 2010, 123:171-180. 10.1242/jcs.057976, 2954245, 20026643.
20. Moreno E, Basler K. dMyc transforms cells into super-competitors. Cell 2004, 117:117-129. 10.1016/S0092-8674(04)00262-4, 15066287.
21. Baker NE. Cell competition. Curr Biol 2011, 21:R11-15. 10.1016/j.cub.2010.11.030, 21215926.
22. Moreno E. Is cell competition relevant to cancer?. Nat Rev Cancer 2008, 8:141-147. 10.1038/nrc2252, 18185517.
23. de la Cova C, Abril M, Bellosta P, Gallant P, Johnston LA. Drosophila myc regulates organ size by inducing cell competition. Cell 2004, 117:107-116. 10.1016/S0092-8674(04)00214-4, 15066286.
24. Vincent JP, Kolahgar G, Gagliardi M, Piddini E. Steep differences in wingless signaling trigger myc-independent competitive cell interactions. Dev Cell 2011, 21:366-374. 10.1016/j.devcel.2011.06.021, 21839923.
25. Senoo-Matsuda N, Johnston LA. Soluble factors mediate competitive and cooperative interactions between cells expressing different levels of Drosophila Myc. Proc Natl Acad Sci USA 2007, 104:18543-18548. 10.1073/pnas.0709021104, 2141813, 18000039.
26. Reid BJ, Li X, Galipeau PC, Vaughan TL. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 2010, 10:87-101. 10.1038/nrc2773, 2879265, 20094044.
27. Paulson TG, Xu L, Sanchez C, Blount PL, Ayub K, Odze RD, Reid BJ. Neosquamous epithelium does not typically arise from Barrett's epithelium. Clin Cancer Res 2006, 12:1701-1706. 10.1158/1078-0432.CCR-05-1810, 16551852.
28. Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology 2010, 138:854-869. 10.1053/j.gastro.2010.01.002, 2853870, 20080098.
29. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994, 25:982-993. 10.1016/0046-8177(94)90057-4, 7927321.
30. Thomas T, Abrams KR, De Caestecker JS, Robinson RJ. Meta analysis: Cancer risk in Barrett's oesophagus. Aliment Pharmacol Ther 2007, 26:1465-1477. 10.1111/j.1365-2036.2007.03528.x, 17900269.
31. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 2008, 168:237-249. 10.1093/aje/kwn121, 18550563.
32. Chen X, Qin R, Liu B, Ma Y, Su Y, Yang CS, Glickman JN, Odze RD, Shaheen NJ. Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol 2008, 8:1. 10.1186/1471-230X-8-1, 2267197, 18190713.
33. Bonde P, Sui G, Dhara S, Wang J, Broor A, Kim IF, Wiley JE, Marti G, Duncan M, Jaffee E, Montgomery E, Maitra A, Harmon JW. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model. J Thorac Cardiovasc Surg 2007, 133:763-769. 10.1016/j.jtcvs.2006.07.044, 17320581.
34. Buskens CJ, Hulscher JBF, van Gulik TM, Ten Kate FJ, van Lanschot JJB. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus. J Surg Res 2006, 135:337-344. 10.1016/j.jss.2006.04.023, 16926029.
35. Su Y, Chen X, Klein M, Fang M, Wang S, Yang CS, Goyal RK. Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus. Lab Invest 2004, 84:753-765. 10.1038/labinvest.3700079, 15094711.
36. Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002, 122:1101-1112. 10.1053/gast.2002.32371, 11910360.
37. Kwak EL, Jankowski J, Thayer SP, Lauwers GY, Brannigan BW, Harris PL, Okimoto RA, Haserlat SM, Driscoll DR, Ferry D, Muir B, Settleman J, Fuchs CS, Kulke MH, Ryan DP, Clark JW, Sgroi DC, Haber DA, Bell DW. Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas. Clin Cancer Res 2006, 12:4283-4287. 10.1158/1078-0432.CCR-06-0189, 16857803.
38. Rygiel AM, Milano F, Ten Kate FJ, Schaap A, Wang KK, Peppelenbosch MP, Bergman JJGHM, Krishnadath KK. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2008, 17:1380-1385. 10.1158/1055-9965.EPI-07-2734, 18559552.
39. Kubo A, Corley DA. Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. Am J Gastroenterol 2007, 102:2323-2330. quiz 2331, 10.1111/j.1572-0241.2007.01374.x, 17581269.
40. Dong LM, Kristal AR, Peters U, Schenk JM, Sanchez CA, Rabinovitch PS, Blount PL, Odze RD, Ayub K, Reid BJ, Vaughan TL. Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutr Cancer 2008, 60:39-48. 2366201, 18444134.
41. Palanca-Wessels MC, Barrett MT, Galipeau PC, Rohrer KL, Reid BJ, Rabinovitch PS. Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology 1998, 114:295-304. 10.1016/S0016-5085(98)70480-9, 9453489.
42. Palanca-Wessels MCA, Klingelhutz A, Reid BJ, Norwood TH, Opheim KE, Paulson TG, Feng Z, Rabinovitch PS. Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis 2003, 24:1183-1190. 10.1093/carcin/bgg076, 1559990, 12807723.
43. Clements DM, Oleesky DA, Smith SC, Wheatley H, Hullin DA, Havard TJ, Bowrey DJ. A study to determine plasma antioxidant concentrations in patients with Barrett's oesophagus. J Clin Pathol 2005, 58:490-492. 10.1136/jcp.2004.023721, 1770670, 15858119.
44. Fountoulakis A, Martin IG, White KLM, Dixon MF, Cade JE, Sue-Ling HM, Wild CP. Plasma and esophageal mucosal levels of vitamin C: role in the pathogenesis and neoplastic progression of Barrett's esophagus. Dig Dis Sci 2004, 49:914-919.
45. Labat-Robert J, Robert L. The effect of cell-matrix interactions and aging on the malignant process. Adv Cancer Res 2007, 98:221-259.
46. Lenski R, Rose M, Simpson S, Tadler. Long-term experimental evolution in Escherichia coli. I. Adaptation and divergence during 2,000 generations. American Naturalist 1991, 138:1315-1341.
47. Rosenzweig RF, Sharp RR, Treves DS, Adams J. Microbial evolution in a simple unstructured environment: genetic differentiation in Escherichia coli. Genetics 1994, 137:903-917. 1206068, 7982572.
48. Czárán TL, Hoekstra RF, Pagie L. Chemical warfare between microbes promotes biodiversity. Proc Natl Acad Sci USA 2002, 99:786-790. 10.1073/pnas.012399899, 117383, 11792831.
49. Andl CD, Mizushima T, Nakagawa H, Oyama K, Harada H, Chruma K, Herlyn M, Rustgi AK. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem 2003, 278:1824-1830. 10.1074/jbc.M209148200, 12435727.
50. Kalabis J, Patterson MJ, Enders GH, Marian B, Iozzo RV, Rogler G, Gimotty PA, Herlyn M. Stimulation of human colonic epithelial cells by leukemia inhibitory factor is dependent on collagen-embedded fibroblasts in organotypic culture. FASEB J 2003, 17:1115-1117.
51. Smalley KSM, Lioni M, Herlyn M. Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Anim 2006, 42:242-247. 10.1290/0604027.1, 17163781.
52. Terry P, Lagergren J, Hansen H, Wolk A, Nyrén O. Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev 2001, 10:365-369. 10.1097/00008469-200108000-00010, 11535879.
53. Henry EB, Carswell A, Wirz A, Fyffe V, McColl KEL. Proton pump inhibitors reduce the bioavailability of dietary vitamin C. Aliment Pharmacol Ther 2005, 22:539-545. 10.1111/j.1365-2036.2005.02568.x, 16167970.